123 (Atripla efavirenz 600mg / emtricitabine 200mg / tenofovir disoproxil fumarate 300mg)
Generic Name: efavirenz/emtricitabine/tenofovir
This pill with imprint "123" is Pink, Elliptical / Oval and has been identified as Atripla efavirenz 600mg / emtricitabine 200mg / tenofovir disoproxil fumarate 300mg. It is supplied by Gilead Sciences, Inc..
Atripla is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. There is positive evidence of human fetal risk during pregnancy. Atripla efavirenz 600mg / emtricitabine 200mg / tenofovir disoproxil fumarate 300mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- efavirenz 600mg / emtricitabine 200mg / tenofovir disoproxil fumarate 300mg
- 20.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gilead Sciences, Inc.
- Inactive Ingredients:
- croscarmellose sodium
hydroxypropyl cellulose (type h)
sodium lauryl sulfate
polyethylene glycol 3350
ferric oxide red
Note: Inactive ingredients may vary.
|NDC Code||Labeler / Repackager|
|54569-5805||A-S Medication Solutions, LLC (repackager)|
|35356-0064||Lake Erie Medical and Surgical Supply (repackager)|
|54868-5643||Physicians Total Care Inc (repackager)|
More about Atripla (efavirenz / emtricitabine / tenofovir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 97 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.